TORONTO, Ontario, April 2, 2018 – Grenville Strategic Royalty Corp. (TSXV: GRC) (“Grenville” or the “Company”) today announced it has signed a royalty purchase agreement with DionyMed Holdings Inc. (“DionyMed”) to provide $1,000,000 CDN in growth capital to DionyMed. Similar to Grenville’s other royalty agreements, the financial terms include an indefinite term, monthly payments, and a buyout provision. In addition, DionyMed has issued to Grenville warrants to purchase up to 100,000 common shares of DionyMed at a strike price of $1.50 CDN per share for a period of 5 years following the issuance date of the warrants. Grenville will have the right to receive additional common share purchase warrants of DionyMed with each additional investment made by Grenville, up to a maximum of 100,000 additional warrants.
Based in Ontario, DionyMed is a holding company and the sole shareholder of Herban Industries, Inc., a California based group operating as a licensed cannabis manufacturer and distributor across the newly regulated State. An early mover in the industry, DionyMed, through its operating entities, sources cannabis distillate, flower, edibles and other related products from licensed suppliers for delivery through it’s truck fleet, to the 300+ licensed dispensaries throughout California.
“We are delighted to invest in this extraordinary team, including serial entrepreneur Edward Fields, and cannabis industry veteran Peter Kampian, the former CFO of Mettrum Health” said Grenville CEO Steve Parry. “We believe DionyMed, through its professional approach to distribution is poised to establish a lead position in the largest established North American market for cannabis products.”
Peter Kampian is a director of Grenville and is also an officer of DionyMed. As such, the transaction constitutes a related party transaction under Canadian Multilateral Instrument 61-101 (“MI 61-101”), but is otherwise exempt from the formal valuation and minority approval requirements of MI 61-101.
About DionyMed Holdings, Inc.
Founded in 2017 by Edward Fields, a Silicon Valley technology executive, DionyMed entered the Cannabis industry as the California regulatory environment shifted in support of the distributor as a critical component of the supply chain. DionyMed recruited Peter Kampian, former CFO of Mettrum Health to the CFO role complementing the existing leadership team and positioning the company to be a leader in the new formed space.
About Grenville
Based in Toronto, Grenville Strategic Royalty Corp. is a publicly-traded royalty company that makes investments in established businesses with revenues of up to $50 million dollars. Grenville generates revenues from royalty payments and buyouts from contracts. The non-dilutive royalty financing structure offered by Grenville competes directly with traditional equity to meet the long-term financing needs of companies on more attractive commercial terms.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Grenville Strategic Royalty Corp.:
Steven Parry
Chief Executive Officer
Tel: (416) 777-0383
